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Abstract  
Diffuse normolipemic plane xanthoma (DNPX) is an uncommon subtype of non-Langerhans histiocytosis. DNPX 
is characterised by xanthelasma palpebrarum, diffuse plane xanthoma of the head, neck, trunk, or extremities, 
and normal plasma lipid levels. The neck is the most common site. We report about a 62-year-old female 
Caucasian patient, who developed an asymptomatic fine wrinkling and loose skin on the neck and décolleté about 
three years ago. The skin colour became yellowish. Xanthelasma was absent. Histopathology of a skin biopsy 
confirmed the diagnosis of DNPX. The patient had a medical history of chronic myeloblastic leukaemia. No other 
laboratory abnormalities were found. Laser treatment was offered but opposed by the patient! 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Diffuse normolipemic plane xanthoma (DNPX) 
was first described by Altman and Winkelmann in 
1962 [1]. It is now considered as an uncommon 
subtype of non - Langerhans histiocytosis [2].  
DNPX is characterized by xanthelasma 
palpebrarum, diffuse plane xanthoma of the head, 
neck, trunk, or extremities, and normal plasma lipid 
levels. The neck is the most common site [1][3]. 
Xanthelasma palpebrarum usually appears first [1].  
The clinical presentation is characterised by 
the presence of symmetric, asymptomatic, yellowish-
orange plaques [1][2]. Oral lesions are extremely rare 
[3]. 
In histology, foam cells (macrophages), and 
variable numbers of Touton giant cells, lymphocytes, 
and foamy histiocytes are present; sometimes only 
foam cells can be seen [4][5]. 
DNPX has been associated with systemic 
diseases, particularly multiple myeloma and 
monoclonal gammopathy [4][5][6]. In other cases, 
malignant haematological or lymphoproliferative 
disorders have been observed [7][8]. 
 
 
Case report 
 
A 62-year-old female Caucasian patient 
developed an asymptomatic fine wrinkling and loose 
skin on the neck and décolleté about three years ago. 
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The skin colour became yellowish (Fig. 1).  
 
Figure 1: Diffuse plane yellowish plaques on neck and décolleté 
 
No other body areas were involved. Her 
medical history was remarkable for chronic 
myeloblastic leukaemia without chemotherapy. She 
did not take any medical drugs. The family history was 
negative for skin diseases. Laboratory investigations 
of metabolic abnormalities remained unremarkable. A 
skin biopsy revealed an atrophic epidermis and a 
massive infiltration of the upper and mid-dermis by 
CD68 positive macrophages including foam cells. 
Here, elastic fibres were somewhat reduced. No 
calcifications were noted (Fig. 2). 
 
Figure 2: Histopathology of diffuse normolipemic plane xanthoma (x 
4). (a) Elastica stain, (b) hematoxylin-eosin, and (c) 
immunoperoxidase for CD68 
 
The diagnosis of DNPX was confirmed. 
Ablative laser therapy was mentioned, but treatment 
was not warranted. 
 
 
Discussion 
 
DNXP is part of the Langerhans cell 
histiocytes-spectrum [9]. No standardised treatment is 
available yet. However, cladribine (2-
chlorodeoxyadenosine) is a candidate drug since it is 
particularly metabolised, phosphorylated and 
concentrated in lymphocytes, macrophages/ 
histocytes and Langerhans cells. The active 
compound is  2-chloroadenosine triphosphate. 
Cladribine has been used successfully in Langerhans 
cell histiocytosis of different types including plane 
xanthoma [10]. There are case reports on regression 
of DNPX during treatment (of associated disorders) 
with cyclosporine A [11] or bexarotene [12]. DNPX 
can be treated by ablative lasers such as erbium-YAG 
laser [13][14]. 
DNXP itself does not cause significant health 
problems although it can be esthetically annoying. Of 
greater importance is the fact, that DNXP has been 
observed in association with monoclonal 
gammopathy, monoclonal gammopathy of unknown 
significance (MGUS) and plasmacytoma [4][5][6][7][8] 
[14][15][16]. In our case, chronic myeloblastic 
leukaemia was evident. Under this view, DNXP may 
have a marker function for unknown myeloproliferative 
disorders and dermatologists should be familiar with 
this uncommon entity. 
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